Results for tag: "Pancreatic Fistula Drug"

The Pancreatic Fistula Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat pancreatic fistulas, which are abnormal connections between the pancreas and other organs. They are typically caused by trauma, surgery, or pancreatic cancer. Pancreatic fistula drugs are used to reduce the risk of infection, reduce pain, and improve the patient's quality of life. Common drugs used to treat pancreatic fistulas include antibiotics, antifungals, and antidiarrheal medications. Several companies are involved in the Pancreatic Fistula Drug market, including AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies produce a variety of drugs to treat pancreatic fistulas, including antibiotics, antifungals, and antidiarrheal medications. Show Less Read more